Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberculosis, Multidrug-Resistant | 40 | 2019 | 944 | 2.060 |
Why?
|
Antitubercular Agents | 42 | 2019 | 1397 | 1.690 |
Why?
|
Directly Observed Therapy | 10 | 2012 | 139 | 0.910 |
Why?
|
Peru | 42 | 2019 | 891 | 0.900 |
Why?
|
Tuberculosis, Pulmonary | 14 | 2019 | 843 | 0.830 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 6 | 2017 | 86 | 0.700 |
Why?
|
Mycobacterium tuberculosis | 24 | 2019 | 1930 | 0.670 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2015 | 591 | 0.580 |
Why?
|
Tuberculosis | 15 | 2016 | 2029 | 0.460 |
Why?
|
Social Support | 6 | 2011 | 2193 | 0.440 |
Why?
|
Sputum | 13 | 2019 | 517 | 0.380 |
Why?
|
Contact Tracing | 5 | 2019 | 275 | 0.370 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2011 | 1903 | 0.350 |
Why?
|
Community Health Services | 7 | 2012 | 659 | 0.300 |
Why?
|
HIV Infections | 14 | 2016 | 17589 | 0.260 |
Why?
|
Developing Countries | 10 | 2016 | 2906 | 0.230 |
Why?
|
Health Services | 2 | 2011 | 755 | 0.230 |
Why?
|
Microbial Sensitivity Tests | 13 | 2019 | 1963 | 0.220 |
Why?
|
Preventive Health Services | 1 | 2006 | 568 | 0.190 |
Why?
|
Poverty | 7 | 2016 | 2720 | 0.180 |
Why?
|
Residence Characteristics | 1 | 2010 | 2122 | 0.180 |
Why?
|
Drug Resistance, Multiple | 4 | 2008 | 255 | 0.170 |
Why?
|
Information Systems | 1 | 2002 | 400 | 0.170 |
Why?
|
Medical Records Systems, Computerized | 2 | 2004 | 1196 | 0.160 |
Why?
|
Anti-HIV Agents | 3 | 2011 | 4576 | 0.160 |
Why?
|
Family Characteristics | 4 | 2013 | 1002 | 0.140 |
Why?
|
Pyrazinamide | 2 | 2015 | 60 | 0.140 |
Why?
|
Mental Health | 1 | 2011 | 3275 | 0.130 |
Why?
|
Quality of Health Care | 2 | 2014 | 4338 | 0.120 |
Why?
|
Rifampin | 4 | 2019 | 351 | 0.120 |
Why?
|
Delivery of Health Care | 2 | 2016 | 5375 | 0.120 |
Why?
|
Mycobacterium | 1 | 2015 | 252 | 0.110 |
Why?
|
Entamoebiasis | 1 | 2013 | 12 | 0.110 |
Why?
|
Protozoan Infections | 1 | 2013 | 38 | 0.110 |
Why?
|
Amebiasis | 1 | 2013 | 33 | 0.110 |
Why?
|
Giardiasis | 1 | 2013 | 28 | 0.110 |
Why?
|
Blastocystis Infections | 1 | 2013 | 17 | 0.110 |
Why?
|
Developed Countries | 1 | 2016 | 452 | 0.110 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2014 | 108 | 0.110 |
Why?
|
Urban Population | 3 | 2011 | 2045 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 2 | 2010 | 1063 | 0.100 |
Why?
|
Russia | 4 | 2017 | 386 | 0.100 |
Why?
|
Anthropology, Cultural | 1 | 2010 | 103 | 0.090 |
Why?
|
Adult | 38 | 2019 | 223818 | 0.090 |
Why?
|
National Health Programs | 2 | 2011 | 442 | 0.080 |
Why?
|
Antibiotics, Antitubercular | 3 | 2005 | 99 | 0.080 |
Why?
|
Qualitative Research | 2 | 2011 | 3143 | 0.080 |
Why?
|
Humans | 66 | 2019 | 768887 | 0.080 |
Why?
|
Financial Management | 1 | 2010 | 161 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1255 | 0.080 |
Why?
|
Young Adult | 18 | 2019 | 60110 | 0.080 |
Why?
|
Models, Organizational | 1 | 2011 | 548 | 0.070 |
Why?
|
Treatment Outcome | 20 | 2015 | 65485 | 0.070 |
Why?
|
Verbal Behavior | 1 | 2008 | 336 | 0.070 |
Why?
|
Treatment Failure | 4 | 2016 | 2663 | 0.070 |
Why?
|
Isoniazid | 3 | 2019 | 288 | 0.070 |
Why?
|
Population Surveillance | 4 | 2011 | 2597 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2012 | 967 | 0.070 |
Why?
|
Stereotyping | 1 | 2008 | 241 | 0.070 |
Why?
|
Male | 38 | 2019 | 365249 | 0.070 |
Why?
|
Health Services Needs and Demand | 2 | 2011 | 1407 | 0.070 |
Why?
|
Adolescent | 19 | 2019 | 89247 | 0.070 |
Why?
|
Female | 40 | 2019 | 397464 | 0.070 |
Why?
|
Trust | 1 | 2010 | 532 | 0.060 |
Why?
|
Medical Errors | 1 | 2014 | 1262 | 0.060 |
Why?
|
Drug Therapy, Combination | 7 | 2015 | 6320 | 0.060 |
Why?
|
Food Supply | 1 | 2011 | 544 | 0.060 |
Why?
|
Cohort Studies | 12 | 2016 | 41800 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3580 | 0.060 |
Why?
|
Incidence | 8 | 2019 | 21545 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 432 | 0.060 |
Why?
|
Focus Groups | 1 | 2010 | 1461 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2009 | 2183 | 0.060 |
Why?
|
Government Programs | 1 | 2006 | 278 | 0.060 |
Why?
|
Social Stigma | 1 | 2011 | 788 | 0.060 |
Why?
|
Middle Aged | 20 | 2019 | 223740 | 0.060 |
Why?
|
Retrospective Studies | 19 | 2015 | 81892 | 0.050 |
Why?
|
Medication Systems, Hospital | 1 | 2004 | 154 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 954 | 0.050 |
Why?
|
Community-Institutional Relations | 1 | 2004 | 209 | 0.050 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2005 | 366 | 0.050 |
Why?
|
Social Environment | 1 | 2007 | 1016 | 0.050 |
Why?
|
Mass Screening | 2 | 2011 | 5455 | 0.050 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12563 | 0.050 |
Why?
|
Prospective Studies | 9 | 2019 | 54950 | 0.050 |
Why?
|
Child, Preschool | 8 | 2019 | 42684 | 0.050 |
Why?
|
Information Management | 1 | 2002 | 100 | 0.050 |
Why?
|
Cost of Illness | 1 | 2010 | 1959 | 0.040 |
Why?
|
Prevalence | 6 | 2016 | 15875 | 0.040 |
Why?
|
Latvia | 2 | 2012 | 15 | 0.040 |
Why?
|
Estonia | 2 | 2012 | 56 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4748 | 0.040 |
Why?
|
Philippines | 2 | 2012 | 95 | 0.040 |
Why?
|
Socioeconomic Factors | 5 | 2012 | 7860 | 0.040 |
Why?
|
Time Factors | 7 | 2013 | 40266 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2667 | 0.040 |
Why?
|
Lesotho | 2 | 2011 | 76 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3908 | 0.040 |
Why?
|
Medication Adherence | 1 | 2011 | 2192 | 0.040 |
Why?
|
Endemic Diseases | 1 | 2000 | 190 | 0.040 |
Why?
|
Language | 1 | 2008 | 1559 | 0.040 |
Why?
|
Patient Compliance | 2 | 2006 | 2701 | 0.040 |
Why?
|
Tuberculin Test | 1 | 2019 | 205 | 0.040 |
Why?
|
Emotions | 1 | 2010 | 2768 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 1999 | 198 | 0.040 |
Why?
|
Primary Prevention | 2 | 2010 | 1187 | 0.040 |
Why?
|
Infant | 5 | 2019 | 36541 | 0.040 |
Why?
|
Health Resources | 1 | 2004 | 951 | 0.040 |
Why?
|
Child | 10 | 2019 | 80969 | 0.040 |
Why?
|
Substance-Related Disorders | 2 | 2012 | 4429 | 0.040 |
Why?
|
Clinical Protocols | 3 | 2015 | 1445 | 0.040 |
Why?
|
Drug Administration Schedule | 5 | 2006 | 4862 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4538 | 0.040 |
Why?
|
Medication Errors | 1 | 2004 | 784 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6546 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2004 | 1406 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 716 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1794 | 0.030 |
Why?
|
Risk Factors | 10 | 2017 | 74971 | 0.030 |
Why?
|
Case-Control Studies | 5 | 2014 | 22294 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2002 | 965 | 0.030 |
Why?
|
Asia | 1 | 2017 | 629 | 0.030 |
Why?
|
Research Design | 2 | 2014 | 6213 | 0.030 |
Why?
|
Aged | 10 | 2019 | 171790 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39394 | 0.030 |
Why?
|
Entamoeba | 1 | 2013 | 5 | 0.030 |
Why?
|
Endolimax | 1 | 2013 | 6 | 0.030 |
Why?
|
Blastocystis hominis | 1 | 2013 | 6 | 0.030 |
Why?
|
Giardia lamblia | 1 | 2013 | 23 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5520 | 0.030 |
Why?
|
Sex Distribution | 2 | 2011 | 2280 | 0.030 |
Why?
|
Program Development | 2 | 2011 | 1300 | 0.020 |
Why?
|
South Africa | 1 | 2017 | 1872 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12093 | 0.020 |
Why?
|
Patient Credit and Collection | 1 | 2010 | 16 | 0.020 |
Why?
|
HIV | 2 | 2012 | 1596 | 0.020 |
Why?
|
Program Evaluation | 2 | 2011 | 2507 | 0.020 |
Why?
|
Laboratories | 1 | 2014 | 463 | 0.020 |
Why?
|
Poverty Areas | 1 | 2011 | 269 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2014 | 878 | 0.020 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 223 | 0.020 |
Why?
|
Drug Resistance, Microbial | 2 | 2005 | 829 | 0.020 |
Why?
|
Internet | 1 | 2002 | 3112 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2011 | 426 | 0.020 |
Why?
|
Financing, Personal | 1 | 2011 | 310 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2010 | 283 | 0.020 |
Why?
|
Health Care Costs | 2 | 2011 | 3270 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8384 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2008 | 210 | 0.020 |
Why?
|
Psychology | 1 | 2009 | 354 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2007 | 301 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1476 | 0.020 |
Why?
|
Peer Group | 1 | 2011 | 698 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18454 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2011 | 718 | 0.020 |
Why?
|
Cost Savings | 1 | 2011 | 915 | 0.020 |
Why?
|
Needs Assessment | 1 | 2011 | 1142 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2009 | 664 | 0.020 |
Why?
|
Education | 1 | 2008 | 533 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 26394 | 0.020 |
Why?
|
Ambulatory Care | 2 | 2008 | 2783 | 0.010 |
Why?
|
Streptomycin | 1 | 2004 | 69 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6242 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9621 | 0.010 |
Why?
|
Retreatment | 1 | 2006 | 600 | 0.010 |
Why?
|
Ethambutol | 1 | 2004 | 59 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1515 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2011 | 2742 | 0.010 |
Why?
|
Infection Control | 1 | 2010 | 984 | 0.010 |
Why?
|
Survival Rate | 2 | 2012 | 12873 | 0.010 |
Why?
|
World Health Organization | 2 | 2000 | 1327 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 242 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13677 | 0.010 |
Why?
|
Inservice Training | 1 | 2004 | 375 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6346 | 0.010 |
Why?
|
Health Plan Implementation | 1 | 2004 | 338 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2014 | 3206 | 0.010 |
Why?
|
Community Health Centers | 1 | 2005 | 469 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10778 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3216 | 0.010 |
Why?
|
Mutation | 1 | 2005 | 30266 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7460 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9682 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2527 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2006 | 857 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13317 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8742 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3856 | 0.010 |
Why?
|
Sampling Studies | 1 | 2000 | 615 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2483 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8095 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13048 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2862 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15955 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8512 | 0.010 |
Why?
|
Electromyography | 1 | 2003 | 1402 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 2875 | 0.010 |
Why?
|
Health Planning | 1 | 1998 | 233 | 0.010 |
Why?
|
Risk Assessment | 3 | 2004 | 24330 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8559 | 0.010 |
Why?
|
International Cooperation | 1 | 2003 | 1436 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15471 | 0.010 |
Why?
|
Morals | 1 | 1998 | 288 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3421 | 0.010 |
Why?
|
Boston | 1 | 2007 | 9375 | 0.010 |
Why?
|
Pregnancy | 2 | 2009 | 30175 | 0.010 |
Why?
|
Body Mass Index | 1 | 2012 | 13054 | 0.010 |
Why?
|
Nurses | 1 | 2004 | 2501 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4784 | 0.010 |
Why?
|
HIV-1 | 1 | 2009 | 6963 | 0.010 |
Why?
|
Health Personnel | 1 | 2004 | 3382 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 3709 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59738 | 0.010 |
Why?
|
Health Surveys | 1 | 2000 | 4055 | 0.010 |
Why?
|
Disease Management | 1 | 1999 | 2537 | 0.000 |
Why?
|
Mental Disorders | 1 | 2008 | 6879 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5544 | 0.000 |
Why?
|
Animals | 1 | 2009 | 169408 | 0.000 |
Why?
|